Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Accessed 10/15/2025, CPSC
Why Choose Tri-Immune Injections
In human Phase 2 clinical trials, doses ranged from 0.3 to 4.5 mg administered once weekly
Some users might experience allergic reactions, including itching or swelling
For instance, manifestation of radiation toxicity at the cellular level involves simultaneous activation of various pro-survival and cytotoxic pathways in a ROS-dependent (indirect effect of radiation) and independent (direct effect of radiation) manner [37, 40, 100]
HIGHLIGHTS: Stable BPC-157, a novel anti-ulcer peptide (1) BPC-157: Healing in different tissues Tendon Healing (4) Bone healing BPC-157 & Neuroprotective effect Effect on Spinal Cord Injury Blood Pressure Tendon Healing (4) Bone healing Stable BPC-157 as anti-ulcer agent (1) Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
US$ 27.09
US$ 22.61
US$ 26.30
US$ 24.53
US$ 29.85
US$ 24.48
US$ 25.50
US$ 22.46
US$ 29.07